Become a Member

written by reader Alzheimer’s drug: BIIB-037 or aducanumab

By Anonymous Questions, October 5, 2017

Biogen just released its study results of its revolutionary Alzheimer’s drug, BIIB-037, or aducanumab. I understand that there may be a way to make even more money than through Biogen. Any ideas on how to make more money on this idea than directly through Biogen?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
9
0
Would love your thoughts, please comment.x
()
x